Table 5.

Estimated medicine requirements in strata representing settings with low, median and high NCD incidence

	Scenario 1					Scenario 2
Medication	Median	Low	High	Median, rounded*	Cost, US$	Median	Low	High	Median, rounded*	Cost, US$
Amlodipine tablets	630	540	810	500	3.00	25 650	16 470	79 200	25 500	153.00
Aspirin tablets	2250	2160	4950	2500	22.25	23 040	19 080	36 720	23 000	204.70
Atenolol tablets	2520	2160	3600	2500	9.75	44 145	34 200	107 640	44 500	173.55
Beclomethasone inhalers	76	70	164	75	360.00	2047	1898	2418	2050	9840.00
Dextrose 50% amps	193	138	368	200	135.00	193	138	368	200	135.00
Enalapril tablets	8280	7560	14 940	8500	279.65	130 590	100 260	332 280	130 500	4293.45
Furosemide tablets	2160	1800	2880	2000	4.40	10 440	4320	18 000	10 500	23.10
Glibenclamide tablets	–	–	–	–	–	8820	12 510	23 940	13 000	45.50
Glyceryl trinitrate tablets	323	255	465	500	23.50	323	255	465	500	23.50
Heparin (10 000 U/ml) phials	32	22	46	25	49.75	32	22	46	25	49.75
Hydralazine phials	16	12	20	25	503.25	16	12	20	25	503.25
Hydrochlorothiazide tablets	1620	1530	2790	1500	3.90	36 720	23 850	112 590	37 000	96.20
Insulin 30/70 phials	80	113	215	125	300.00	160	114	305	175	420.00
Metformin tablets	–	–	–	–	–	112 455	79 380	215 190	112 500	787.50
Prednisone tablets	636	543	1533	500	10.30	636	543	1533	500	10.30
Salbutamol inhalers	84	71	210	100	332.00	1532	1408	2220	1525	5063.00
Simvastatin tablets	2250	2160	4950	2500	42.00	23 040	19 080	36 720	23 000	386.40
Total					2078.75					22 208.20

*Rounded to the nearest 500 or 25 units as appropriate.

NCD, non-communicable disease.